Immunogenicity of Standard‐Titer Measles Vaccine in HIV‐1–Infected and Uninfected Zambian Children: An Observational Study | Zendy

William J. Moss | Zendy; Susana Scott | Zendy; Nanthalile Mugala | Zendy; Zaza M. Ndhlovu | Zendy; Judy A. Beeler | Zendy; Susette Audet | Zendy; Mirriam Ngala | Zendy; Sheila Mwangala | Zendy; Chansa NkongaMwangilwa | Zendy; Judith J. Ryon | Zendy; Mwaka Monze | Zendy; Francis Kasolo | Zendy; Thomas C. Quinn | Zendy; Simon Cousens | Zendy; Diane E. Griffin | Zendy; Felicity Cutts | Zendy

Open Access

Immunogenicity of Standard‐Titer Measles Vaccine in HIV‐1–Infected and Uninfected Zambian Children: An Observational Study

Author(s) -

William J. Moss,

Susana Scott,

Nanthalile Mugala,

Zaza M. Ndhlovu,

Judy A. Beeler,

Susette Audet,

Mirriam Ngala,

Sheila Mwangala,

Chansa NkongaMwangilwa,

Judith J. Ryon,

Mwaka Monze,

Francis Kasolo,

Thomas C. Quinn,

Simon Cousens,

Diane E. Griffin,

Felicity Cutts

Publication year - 2007

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/519169

Subject(s) - immunogenicity , virology , measles , titer , medicine , measles vaccine , observational study , immunology , vaccination , virus , antibody

Achieving the level of population immunity required for measles elimination may be difficult in regions of high human immunodeficiency virus type 1 (HIV-1) prevalence, because HIV-1-infected children may be less likely to respond to or maintain protective antibody levels after vaccination.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research